Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium

eLife

Volumn 4, Issue JULY 2015, 2015, Pages

  Cheung, Lydia W T ^a   Walkiewicz, Katarzyna W ^b   Besong, Tabot Md ^b   Guo, Huifang ^a   Hawke, David H ^a   Arold, Stefan T ^b   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P85 ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN BINDING; PTEN PROTEIN, HUMAN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GEL FILTRATION; GENE MUTATION; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; RADIOIMMUNOPRECIPITATION; SEDIMENTATION RATE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOLOGICAL MODEL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR MODEL; PROTEIN MULTIMERIZATION;

CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84938364539     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.06866     Document Type: Article

References (49)

1. Asano T, Yao Y, Shin S, McCubrey J, Abbruzzese JL, Reddy SA. 2005. Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells. Cancer Research 65:9164–9168. doi: 10.1158/0008-5472.CAN-05-0779.
2. Batra-Safferling R, Granzin J, Modder S, Hoffmann S, Willbold D. 2010. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding. Biological Chemistry 391:33–42. doi: 10.1515/BC.2010.003.
3. Benkert P, Schwede T, Tosatto SC. 2009. QMEANclust: estimation of protein model quality by combining a composite scoring function with structural density information. BMC Structural Biology 9:35. doi: 10.1186/1472-6807-9-35.
4. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. 2012. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery 2:401–404. doi: 10.1158/2159-8290.CD-12-0095.
5. Chagpar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD, Anderson DH. 2010. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences of USA 107:5471–5476. doi: 10.1073/pnas.0908899107.
6. Chamberlain MD, Berry TR, Pastor MC, Anderson DH. 2004. The p85alpha subunit of phosphatidylinositol 3’-kinase binds to and stimulates the GTPase activity of Rab proteins. The Journal of Biological Chemistry 279:48607–48614. doi: 10.1074/jbc.M409769200.
7. Chamberlain MD, Oberg JC, Furber LA, Poland SF, Hawrysh AD, Knafelc SM, McBride HM, Anderson DH. 2010. Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR trafficking. Cellular Signalling 22:1562–1575. doi: 10.1016/j.cellsig.2010.05.025.
8. Cheung LW, Hennessy BT, Li J, Yu S, Myers AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F, Ju Z, Cantley LC, Scherer SE, Liang H, Lu KH, Broaddus RR, Mills GB. 2011. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discovery 1:170–185. doi: 10.1158/2159-8290.CD-11-0039.
9. Cole JL, Lary JW, P Moody T, Laue TM. 2008. Analytical ultracentrifugation: sedimentation velocity and sedimentation equilibrium. Methods in Cell Biology 84:143–179. doi: 10.1016/S0091-679X(07)84006-4.
10. Cuevas BD, Lu Y, Mao M, Zhang J, LaPushin R, Siminovitch K, Mills GB. 2001. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. The Journal of Biological Chemistry 276:27455–27461. doi: 10.1074/jbc.M100556200.
11. Davletov B, Perisic O, Williams RL. 1998. Calcium-dependent membrane penetration is a hallmark of the C2 domain of cytosolic phospholipase A2 whereas the C2A domain of synaptotagmin binds membranes electrostatically. The Journal of Biological Chemistry 273:19093–19096. doi: 10.1074/jbc.273.30.19093.
12. Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC. 2001. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. The Journal of Biological Chemistry 276:4872–4878. doi: 10.1074/jbc.M008901200.
13. Fukuda M, Kojima T, Mikoshiba K. 1996. Phospholipid composition dependence of Ca2+-dependent phospholipid binding to the C2A domain of synaptotagmin IV. The Journal of Biological Chemistry 271:8430–8434. doi: 10.1074/jbc.271.14.8430.
14. Guo H, Qiao G, Ying H, Li Z, Zhao Y, Liang Y, Yang L, Lipkowitz S, Penninger JM, Langdon WY, Zhang J. 2012. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Cell Reports 1:472–482. doi: 10.1016/j.celrep.2012.04.008.
15. Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. 2005. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. The Journal of Biological Chemistry 280:32081–32089. doi: 10.1074/jbc.M502876200.
16. Harpur AG, Layton MJ, Das P, Bottomley MJ, Panayotou G, Driscoll PC, Waterfield MD. 1999. Intermolecular interactions of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase. The Journal of Biological Chemistry 274:12323–12332. doi: 10.1074/jbc.274.18.12323.
17. Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H, Barnett J, Leslie NR, Cheng S, Shepherd PR, Gout I, Downes CP, Lamb RF. 2004. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. The Journal of Cell Biology 166:213–223. doi: 10.1083/jcb.200403069.
18. Hernandez M, Ghersi D, Sanchez R. 2009. SITEHOUND-web: a server for ligand binding site identification in protein structures. Nucleic Acids Research 37:W413–W416. doi: 10.1093/nar/gkp281.
19. Humphrey SJ, Yang G, Yang P, Fazakerley DJ, Stockli J, Yang JY, James DE. 2013. Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metabolism 17:1009-1020. doi: 10.1016/j.cmet.2013.04.010.
20. Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman KK, Lorenzo M, Li H, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker JS, de Sauvage FJ, Backer JM, Seshagiri S. 2009. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell 16:463-174. doi: 10.1016/j.ccr.2009.10.016.
21. Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, Zhang J, Signoretti S, Loda M, Roberts TM, Zhao JJ. 2008. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454: 776-779. doi: 10.1038/nature07091.
22. Jimenez C, Portela RA, Mellado M, Rodriguez-Frade JM, Collard J, Serrano A, Martinez AC, Avila J, Carrera AC. 2000. Role of the PI3K regulatory subunit in the control of actin organization and cell migration. The Journal of Cell Biology 151:249-262. doi: 10.1083/jcb.151.2.249.
23. Konarev PV, Petoukhov MV, Volkov VV, Svergun DI. 2006. ATSAS 2.1, a program package for small-angle scattering data analysis. Journal of Applied Crystallography 39:277-286. doi: 10.1107/S0021889806004699.
24. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. Journal of Molecular Biology 372:774-797. doi: 10.1016/j.jmb.2007.05.022.
25. Ladbury JE, Arold ST. 2011. Energetics of Src homology domain interactions in receptor tyrosine kinase-mediated signaling. Methods Enzymol 488:147-183. doi: 10.1016/B978-0-12-381268-1.00007-0.
26. Lamothe B, Yamada M, Schaeper U, Birchmeier W, Lax I, Schlessinger J. 2004. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Molecular and Cellular Biology 24:5657-5666. doi: 10.1128/MCB.24.13.5657-5666.2004.
27. Layton MJ, Harpur AG, Panayotou G, Bastiaens PI, Waterfield MD. 1998. Binding of a diphosphotyrosine-containing peptide that mimics activated platelet-derived growth factor receptor beta induces oligomerization of phosphatidylinositol 3-kinase. The Journal of Biological Chemistry 273:33379-33385. doi: 10.1074/jbc.273.50.33379.
28. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP. 1999. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323-334. doi: 10.1016/S0092-8674(00)81663-3.
29. Liang J, Chen JK, Schreiber ST, Clardy J. 1996. Crystal structure of P13K SH3 domain at 20 angstroms resolution. Journal of Molecular Biology 257:632-643. doi: 10.1006/jmbi.1996.0190.
30. London N, Raveh B, Cohen E, Fathi G, Schueler-Furman O. 2011. Rosetta FlexPepDock web server-high resolution modeling of peptide-protein interactions. Nucleic Acids Research 39:W249-W253. doi: 10.1093/nar/gkr431.
31. Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC. 2005. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. The Journal of Cell Biology 170:455-464. doi: 10.1083/jcb.200503088.
32. Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, Chen J. 011. WWP2 is an E3 ubiquitin ligase for PTEN. Nature Cell Biology 13:728-733. doi: 10.1038/ncb2240.
33. Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y, Schneidman-Duhovny D, Wolfson HJ, Backer JM, Williams RL. 2007. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317:239-242. doi: 10.1126/science.1135394.
34. Musacchio A, Cantley LC, Harrison SC. 1996. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit. Proceedings of the National Academy of Sciences of USA 93:14373-14378. doi: 10.1073/pnas.93.25.14373.
35. Odriozola L, Singh G, Hoang T, Chan AM. 2007. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. The Journal of Biological Chemistry 282:23306-23315. doi: 10.1074/jbc.M611240200.
36. Rabinovsky R, Pochanard P, McNear C, Brachmann SM, Duke-Cohan JS, Garraway LA, Sellers WR. 2009. P 85 Associates ith unphosphorylated PTEN and the PTEN-associated complex. Molecular and Cellular Biology 29:5377-5388. doi: 10.1128/MCB.01649-08.
37. Renzoni DA, Pugh DJ, Siligardi G, Das P, Morton CJ, Rossi C, Waterfield MD, Campbell ID, Ladbury JE. 1996. Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline- rich binding site on the p85 subunit of PI3-kinase. Biochemistry 35:15646-15653. doi: 10.1021/bi20969.
38. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J. 1996. Activation of phosph inositide 3-kinase by interaction with Ras and by point mutation. The EMBO Journal 15:2442-2451.
39. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101. doi: 10.1126/science.1106148.
40. Schuck P. 2000. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophysical Journal 78:1606-1619. doi: 10.1016/S0006-3495(00)76713-0.
41. Schuck P. 2003. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Analytical Biochemistry 320:104-124. doi: 10.1016/S0003-2697(03)00289-6.
42. Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT. 2000. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen- stimulated and transformed cells. Cancer Research 60:3504-3513.
43. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, Pandolfi PP. 2007. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128:141-156. doi: 10.1016/j.cell.2006.11.040.
44. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. 2002. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Molecular and Cellular Biology 22:965-977. doi: 10.1128/MCB.22.3.965-977.2002.
45. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR. 2000. Phosphorylation of the PTEN tail regulates protein stability and function. Molecular and Cellular Biology 20:5010-5018. doi: 10.1128/MCB.20.14.5010-5018.2000.
46. Wang J, Auger KR, Jarvis L, Shi Y, Roberts TM. 1995. Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. The Journal of Biological Chemistry 270:12774-12780. doi: 10.1074/jbc.270.21.12774.
47. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, Jiang X. 2007. NEDD4-1 is a proto-oncogenic ubiquitin ligasefor PTEN. Cell 128:129-139. doi: 10.1016/j.cell.2006.11.039.
48. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. 1998. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Molecular and Cellular Biology 18:1379-1387.
49. Zheng Y, Bagrodia S, Cerione RA. 1994. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. The Journal of Biological Chemistry 269:18727-18730.